Blood Cancer Journal (Oct 2023)
Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
- Surbhi Sidana,
- Hitomi Hosoya,
- Alexandria Jensen,
- Lawrence Liu,
- Anmol Goyal,
- Vanna Hovanky,
- Bita Sahaf,
- Sushma Bharadwaj,
- Theresa Latchford,
- Sally Arai,
- Sheryl Leahy,
- Matthew Mei,
- Lihua E. Budde,
- Lori S. Muffly,
- Matthew J. Frank,
- Saurabh Dahiya,
- Myo Htut,
- David Miklos,
- Murali Janakiram
Affiliations
- Surbhi Sidana
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Hitomi Hosoya
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Alexandria Jensen
- Quantitative Sciences Unit, Stanford University School of Medicine
- Lawrence Liu
- City of Hope Cancer Center
- Anmol Goyal
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Vanna Hovanky
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Bita Sahaf
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Sushma Bharadwaj
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Theresa Latchford
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Sally Arai
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Sheryl Leahy
- City of Hope Cancer Center
- Matthew Mei
- City of Hope Cancer Center
- Lihua E. Budde
- City of Hope Cancer Center
- Lori S. Muffly
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Matthew J. Frank
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Saurabh Dahiya
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Myo Htut
- City of Hope Cancer Center
- David Miklos
- Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine
- Murali Janakiram
- City of Hope Cancer Center
- DOI
- https://doi.org/10.1038/s41408-023-00929-0
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 5
Abstract
No abstracts available.